Skip to main content

Table 2 Treatment modalities

From: Cytokines levels, Severity of acute mucositis and the need of PEG tube installation during chemo-radiation for head and neck cancer - a prospective pilot study

Parameter

No. of patients

%

Surgery

  

No

11

73.3

Yes

4

26.7

Radiotherapy

  

Total tumor dose, Gy

  

60

2

13.3

66

2

13.3

70

10

66.7

72

1

6.7

RT Technique

  

2D

3

20

3D

10

66.7

IMRT

2

13.3

Parotid sparing

  

No

13

86.7

Yes

2

13.3

RT interruptions

  

Yes (3 d, 6 d, NOS)

3

20

No

12

80

Chemotherapy

  

Neoadjuvant chemotherapy

  

No

7

46.6

Yes:

  

Cisplatin/5FU1

6

40

Carboplatin/5FU2

1

6.7

Docetaxel/5FU/Cisplatin3

1

6.7

Concomitant Chemotherapy

  

Carboplatin4

1

6.7

Cisplatin5

14

93.3

  1. 1 Cisplatin 100 mg/m2, I.V., day 1; 5-Fluorouracil 1000 mg/m2 I.V., continuous infusion, days 1-5, every 21 days
  2. 2 Carboplatin AUC 2, I.V., day 1; 5-Fluorouracil 1000 mg/m2 I.V. continuous infusion, days 1-5, every 21 days
  3. 3 Docetaxel 75 mg, Cisplatin 75 mg I.V. day 1; 5-Fluorouracil 750 mg I.V., continuous infusion, days 1-5, every 21 days
  4. 4 Carboplatin ACU 2, I.V., weekly
  5. 5 Cisplatin 40 mg/m2 I.V., weekly